Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Handa pharmaceuticals announces tentative approval of SEROQUEL XR
>> article
Handa pharmaceuticals announces tentative approval of SEROQUEL XR
Editor:bianch Clicks:
0
Date:2010-12-16 10:10:02
Keyword:
Handa pharmaceuticals Fosun Pharmaceutical
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
National guideline issued to improve medical industry
CSPC to build biopharmaceutical base in xingtai
Guangzhou offers special policies to attract foreign pharma firms
Import and export values of China's pharmaceutical products in 2014
Tianjin improving pharmaceutical R&D
Puruite builds pharmaceutical intermediate project...
Fosun buys US insurance company
Beijing's E-town pharmaceutical business is&nb...
Fujian supports pharmaceutical industry with ...
Tasly Pharmaceutical H1 profit up 24%
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
